You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 3, July 17, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Performance-Enhancing Drugs, Fair Competition, and Olympic Sport

Don H. Catlin, MD; Thomas H. Murray, PhD

JAMA. 1996;276(3):231-237.


Abstract

Drug control has become an important component of Olympic sport. At the Atlanta Centennial Olympic Games, urine samples will be tested for prohibited substances, including stimulants, narcotics, anabolic agents, diuretics, peptides, and glycoprotein hormones as well as prohibited methods of enhancing performance, including blood doping and pharmacological, chemical, and physical manipulation of the urine. Drug testing programs must address short-acting stimulants, β-blockers, and diuretics; training drugs such as anabolic steroids; and drugs affecting the detectability of other drugs. Programs include short- or no-notice testing during training periods, testing at qualifying competitions, and testing at the Olympic Games. Procedures and disposition that occur when a prohibited substance is found in an athlete competing in an Olympic sport are discussed. An analysis of the ethics of the use of performance-enhancing drugs in sports and of drug control in terms of fair competition and the impact of enhancement technologies of the meaning of sports also is presented.



Author Affiliations

From the Departments of Molecular and Medical Pharmacology and Medicine, University of California, Los Angeles, and the UCLA Olympic Analytical Laboratory, (Dr Catlin); and the Center for Biomedical Ethics, Case Western Reserve University, Cleveland, Ohio (Dr Murray).


Footnotes

Reprints: Don H. Catlin, MD, UCLA Olympic Analytical Laboratory, 2122 Granville Ave, Los Angeles, CA 90025-6106.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Why we should allow performance enhancing drugs in sport
Savulescu et al.
Br. J. Sports. Med. 2004;38:666-670.
FULL TEXT  

Cyclist's doping associated with cerebral sinus thrombosis
Lage et al.
Neurology 2002;58:665-665.
FULL TEXT  

Use of Ergogenic Aids by Athletes
Silver
J Am Acad Orthop Surg 2001;9:61-70.
ABSTRACT | FULL TEXT  

Trace Contamination of Over-the-Counter Androstenedione and Positive Urine Test Results for a Nandrolone Metabolite
Catlin et al.
JAMA 2000;284:2618-2621.
ABSTRACT | FULL TEXT  

PERCEPTUAL MAPPING OF BANNED SUBSTANCES IN ATHLETICS: Gender- and Sport-Defined Differences
Pan and Baker
Journal of Sport and Social Issues 1998;22:170-182.
ABSTRACT  

Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine
Catlin et al.
Clin. Chem. 1997;43:1280-1288.
ABSTRACT | FULL TEXT  

Drug Testing in Sport: Bayes Theorem Meets Advanced Technology
Carlen
JAMA 1996;276:1471-1471.
ABSTRACT  

An Olympic Medical Legacy
Cantwell and Fontanarosa
JAMA 1996;276:248-249.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.